Comparative in vitro activity of daptomycin (LY146032) and vancomycin against gram-positive cocci determined using a pharmacokinetic model
- 1 August 1989
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 8 (8) , 734-737
- https://doi.org/10.1007/bf01963764
Abstract
The activity of daptomycin (LY146032) and vancomycin was compared for methicillin-sensitive and methicillin-resistant (MRSA) strains ofStaphylococcus aureus and forEnterococcus faecalis, using a semi-automated model that allows examination of time-kill curves with diminishing drug concentrations, thus reflecting in vivo pharmacokinetics. Exposure to daptomycin resulted in rapid killing of all strains of staphylococci andEnterococcus faecalis tested. Methicillin-sensitive staphylococcal strains appeared marginally more susceptible than MRSA. By contrast, the activity of vancomycin appeared much reduced. For all strains, >90% kill was not observed within 24 h.Enterococcus faecalis was uniformly less susceptible to both agents than were staphylococci. The results suggest that despite similar values for MICs, the activity of daptomycin against strains ofStaphylococcus aureus andEnterococcus faecalis is comparable to and may exceed that of vancomycin, although the significance of such differences is uncertain.This publication has 19 references indexed in Scilit:
- Daptomycin (LY146032) treatment of experimental enterococcal endocarditisAntimicrobial Agents and Chemotherapy, 1988
- Comparison of the Invesligalional drug, LV146032, with vancomycin in experimental pneumonia due to methidillln-resistant Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 1988
- Activity of LY146032 in vitro and in experimental enterococcal pyelonephritisAntimicrobial Agents and Chemotherapy, 1987
- The effect of cultural conditions on the activity of LY146032 against staphylococci and streptococciJournal of Antimicrobial Chemotherapy, 1987
- In-vitro susceptibility of Gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicinJournal of Antimicrobial Chemotherapy, 1987
- In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocciAntimicrobial Agents and Chemotherapy, 1987
- In vitro activity of LY146032 against staphylococci, streptococci, and enterococciAntimicrobial Agents and Chemotherapy, 1986
- New In Vitro Model to Study the Effect of Antibiotic Concentration and Rate of Elimination on Antibacterial ActivityAntimicrobial Agents and Chemotherapy, 1978
- A Simple Dilution Analog Computer for Simulation of Drug Distribution ProcessesJournal of Pharmaceutical Sciences, 1969
- An Experimental Model for the Study of the Antibacterial Activity of the SulfonamidesChemotherapy, 1968